These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33254097)

  • 21. Placental Growth Factor and Soluble, Fms-Like Tyrosine Kinase-1 in Preeclampsia: A Case-Cohort (PEARL) Study.
    Fillion A; Guerby P; Lachance C; Comeau MP; Bussières MC; Doucet-Gingras FA; Zérounian S; Demers S; Laforest G; Menzies D; Bujold E
    J Obstet Gynaecol Can; 2020 Oct; 42(10):1235-1242. PubMed ID: 32718871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
    Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
    Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia?
    Kwiatkowski S; Dołęgowska B; Kwiatkowska E; Rzepka R; Marczuk N; Loj B; Mikolajek-Bedner W; Torbe A
    J Matern Fetal Neonatal Med; 2019 Jan; 32(1):11-20. PubMed ID: 28816071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.
    Espinoza J; Romero R; Nien JK; Gomez R; Kusanovic JP; Gonçalves LF; Medina L; Edwin S; Hassan S; Carstens M; Gonzalez R
    Am J Obstet Gynecol; 2007 Apr; 196(4):326.e1-13. PubMed ID: 17403407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
    Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
    J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
    Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First and Second Trimester Serum sFlt-1/PlGF Ratio and Subsequent Preeclampsia: A Systematic Review.
    Yusuf AM; Kahane A; Ray JG
    J Obstet Gynaecol Can; 2018 May; 40(5):618-626. PubMed ID: 28927814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total Versus Free Placental Growth Factor Levels in the Pathogenesis of Preeclampsia.
    Lecarpentier E; Zsengellér ZK; Salahuddin S; Covarrubias AE; Lo A; Haddad B; Thadhani RI; Karumanchi SA
    Hypertension; 2020 Sep; 76(3):875-883. PubMed ID: 32654553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
    Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
    Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
    Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary Microvascular Function Following Severe Preeclampsia.
    Honigberg MC; Economy KE; Pabón MA; Wang X; Castro C; Brown JM; Divakaran S; Weber BN; Barrett L; Perillo A; Sun AY; Antoine T; Farrohi F; Docktor B; Lau ES; DeFaria Yeh D; Natarajan P; Sarma AA; Weisbrod RM; Hamburg NM; Ho JE; Roh JD; Wood MJ; Scott NS; Di Carli MF
    Hypertension; 2024 Jun; 81(6):1272-1284. PubMed ID: 38563161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preeclampsia and superimposed preeclampsia: The same disease? The role of angiogenic biomarkers.
    Costa RA; Hoshida MS; Alves EA; Zugaib M; Francisco RP
    Hypertens Pregnancy; 2016 May; 35(2):139-49. PubMed ID: 26930132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
    Stepan H; Hund M; Dilba P; Sillman J; Schlembach D
    Clin Chem Lab Med; 2019 Aug; 57(9):1339-1348. PubMed ID: 31323000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.